Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis

NCT02603146 is registered in ClinicalTrials.gov with National Institute of Allergy and Infectious Diseases (NIAID) as lead sponsor.

NCT NCT02603146
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02603146 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Strategy to Prevent the Onset of Clinically-Apparent Rheumatoid Arthritis
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Phase
Phase 2
Overall status
Terminated
Start date
April 27, 2016
Completion date
November 1, 2022
Enrollment
144 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

healthy participants, rheumatoid arthritis (ra) prevention